Angiotensin II Pseudopeptides Containing 1,3,5-Trisubstituted Benzene Scaffolds with High AT2 Receptor Affinity
摘要:
Two 1,3,5-trisubstituted aromatic scaffolds intended to serve as gamma-turn mimetics have been synthesized and incorporated in five pseudopeptide analogues of angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), replacing Val-Tyr-Ile, Val-Tyr, or Tyr-Ile. All the tested compounds exhibited nanomolar affinity for the AT(2) receptor with the best compound (3) having a K-i of 1.85 nM. Four pseudopeptides were AT(2) selective, while one (5) also exhibited good affinity for the AT(1) receptor (K-i = 30.3 nM). This pseudopeptide exerted full agonistic activity in an AT(2) receptor induced neurite outgrowth assay but displayed no agonistic effect in an AT(2) receptor functional assay. Molecular modeling, using the program DISCOtech, showed that the high-affinity ligands could interact similarly with the AT(2) receptor as other ligands with high affinity for this receptor. A tentative agonist model is proposed for AT(2) receptor activation by angiotensin 11 analogues. We conclude that the 1,3,5-trisubstituted benzene rings can be conveniently prepared and are suitable as gamma-turn mimics.
Angiotensin II Pseudopeptides Containing 1,3,5-Trisubstituted Benzene Scaffolds with High AT2 Receptor Affinity
摘要:
Two 1,3,5-trisubstituted aromatic scaffolds intended to serve as gamma-turn mimetics have been synthesized and incorporated in five pseudopeptide analogues of angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), replacing Val-Tyr-Ile, Val-Tyr, or Tyr-Ile. All the tested compounds exhibited nanomolar affinity for the AT(2) receptor with the best compound (3) having a K-i of 1.85 nM. Four pseudopeptides were AT(2) selective, while one (5) also exhibited good affinity for the AT(1) receptor (K-i = 30.3 nM). This pseudopeptide exerted full agonistic activity in an AT(2) receptor induced neurite outgrowth assay but displayed no agonistic effect in an AT(2) receptor functional assay. Molecular modeling, using the program DISCOtech, showed that the high-affinity ligands could interact similarly with the AT(2) receptor as other ligands with high affinity for this receptor. A tentative agonist model is proposed for AT(2) receptor activation by angiotensin 11 analogues. We conclude that the 1,3,5-trisubstituted benzene rings can be conveniently prepared and are suitable as gamma-turn mimics.
Two 1,3,5-trisubstituted aromatic scaffolds intended to serve as gamma-turn mimetics have been synthesized and incorporated in five pseudopeptide analogues of angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), replacing Val-Tyr-Ile, Val-Tyr, or Tyr-Ile. All the tested compounds exhibited nanomolar affinity for the AT(2) receptor with the best compound (3) having a K-i of 1.85 nM. Four pseudopeptides were AT(2) selective, while one (5) also exhibited good affinity for the AT(1) receptor (K-i = 30.3 nM). This pseudopeptide exerted full agonistic activity in an AT(2) receptor induced neurite outgrowth assay but displayed no agonistic effect in an AT(2) receptor functional assay. Molecular modeling, using the program DISCOtech, showed that the high-affinity ligands could interact similarly with the AT(2) receptor as other ligands with high affinity for this receptor. A tentative agonist model is proposed for AT(2) receptor activation by angiotensin 11 analogues. We conclude that the 1,3,5-trisubstituted benzene rings can be conveniently prepared and are suitable as gamma-turn mimics.